Geode Capital Management, LLC Glaukos Corp Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,172,016 shares of GKOS stock, worth $168 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,172,016

Previous 1,105,882 5.98%

Holding current value

$168 Million

Previous $131 Million 16.66%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$113.62 - $135.39 $7.51 Million - $8.95 Million	66,134 Added 5.98%	1,172,016 $153 Million
Q2 2024 Aug 09, 2024	BUY	$89.48 - $118.35 $6.08 Million - $8.04 Million	67,951 Added 6.55%	1,105,882 $131 Million
Q1 2024 May 13, 2024	BUY	$76.4 - $96.33 $2.29 Million - $2.88 Million	29,943 Added 2.97%	1,037,931 $97.9 Million
Q4 2023 Feb 13, 2024	BUY	$59.53 - $85.11 $3.38 Million - $4.83 Million	56,741 Added 5.96%	1,007,988 $80.1 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $2.58 Million - $2.94 Million	37,198 Added 4.07%	951,247 $71.6 Million
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $1.97 Million - $3.09 Million	43,417 Added 4.99%	914,049 $65.1 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $1.79 Million - $2.14 Million	40,757 Added 4.91%	870,632 $43.6 Million
Q4 2022 Feb 13, 2023	BUY	$40.82 - $57.75 $1.27 Million - $1.8 Million	31,105 Added 3.89%	829,875 $36.2 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $784,710 - $979,882	16,753 Added 2.14%	798,770 $42.5 Million
Q2 2022 Aug 12, 2022	SELL	$34.86 - $63.77 $212,924 - $389,507	-6,108 Reduced 0.78%	782,017 $35.5 Million
Q1 2022 May 13, 2022	BUY	$44.33 - $57.82 $1.32 Million - $1.72 Million	29,804 Added 3.93%	788,125 $45.6 Million
Q4 2021 Feb 11, 2022	BUY	$40.27 - $56.99 $418,969 - $592,923	10,404 Added 1.39%	758,321 $33.7 Million
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $189,625 - $336,751	3,998 Added 0.54%	747,917 $36 Million
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $3.5 Million - $4.68 Million	47,914 Added 6.88%	743,919 $63.1 Million
Q1 2021 May 12, 2021	BUY	$70.43 - $97.42 $3.99 Million - $5.52 Million	56,650 Added 8.86%	696,005 $58.4 Million
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $2.3 Million - $3.54 Million	47,097 Added 7.95%	639,355 $48.1 Million
Q3 2020 Nov 13, 2020	BUY	$37.23 - $50.97 $633,096 - $866,744	17,005 Added 2.96%	592,258 $29.3 Million
Q2 2020 Aug 13, 2020	BUY	$28.78 - $46.83 $1.02 Million - $1.66 Million	35,507 Added 6.58%	575,253 $22.1 Million
Q1 2020 May 14, 2020	BUY	$25.53 - $70.14 $965,136 - $2.65 Million	37,804 Added 7.53%	539,746 $16.7 Million
Q4 2019 Feb 13, 2020	BUY	$54.18 - $65.64 $2.71 Million - $3.29 Million	50,061 Added 11.08%	501,942 $27.3 Million
Q3 2019 Nov 12, 2019	BUY	$58.58 - $83.91 $1.28 Million - $1.83 Million	21,801 Added 5.07%	451,881 $28.2 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $2.65 Million - $3.28 Million	41,653 Added 10.72%	430,080 $32.4 Million
Q1 2019 May 14, 2019	BUY	$50.75 - $80.54 $1.18 Million - $1.87 Million	23,201 Added 6.35%	388,427 $30.4 Million
Q4 2018 Feb 13, 2019	BUY	$52.18 - $67.93 $2.34 Million - $3.05 Million	44,867 Added 14.01%	365,226 $20.5 Million
Q3 2018 Nov 13, 2018	BUY	$38.13 - $68.37 $921,754 - $1.65 Million	24,174 Added 8.16%	320,359 $20.8 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $435,456 - $701,744	15,766 Added 5.62%	296,185 $12 Million
Q1 2018 May 15, 2018	BUY	$26.05 - $34.5 $116,756 - $154,629	4,482 Added 1.62%	280,419 $8.65 Million
Q4 2017 Feb 13, 2018	BUY	$24.5 - $36.01 $55,566 - $81,670	2,268 Added 0.83%	275,937 $7.08 Million
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $4.61 Million - $6.2 Million	147,518 Added 116.94%	273,669 $9.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	126,151	126,151 $5.23 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.84B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Glaukos Corp Transaction History